Next Article in Journal
Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach
Next Article in Special Issue
Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides
Previous Article in Journal
Capsaicin-Sensitive Sensory Nerves Are Necessary for the Protective Effect of Ghrelin in Cerulein-Induced Acute Pancreatitis in Rats
Previous Article in Special Issue
MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(7), 1404;

Histone Lysine Methylation and Neurodevelopmental Disorders

Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea
Department of Functional Genomics, University of Science and Technology, Daejeon 34113, Korea
Department of Biological Sciences, Konkuk University, Seoul 05029, Korea
Department of Brain & Cognitive Sciences, DGIST, Daegu 42988, Korea
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 13 June 2017 / Revised: 25 June 2017 / Accepted: 27 June 2017 / Published: 30 June 2017
(This article belongs to the Special Issue Epigenetics of Neurodevelopmental Disorders)
Full-Text   |   PDF [987 KB, uploaded 30 June 2017]   |  


Methylation of several lysine residues of histones is a crucial mechanism for relatively long-term regulation of genomic activity. Recent molecular biological studies have demonstrated that the function of histone methylation is more diverse and complex than previously thought. Moreover, studies using newly available genomics techniques, such as exome sequencing, have identified an increasing number of histone lysine methylation-related genes as intellectual disability-associated genes, which highlights the importance of accurate control of histone methylation during neurogenesis. However, given the functional diversity and complexity of histone methylation within the cell, the study of the molecular basis of histone methylation-related neurodevelopmental disorders is currently still in its infancy. Here, we review the latest studies that revealed the pathological implications of alterations in histone methylation status in the context of various neurodevelopmental disorders and propose possible therapeutic application of epigenetic compounds regulating histone methylation status for the treatment of these diseases. View Full-Text
Keywords: epigenetic changes; histone lysine methylation; lysine methyltransferase; lysine demethylase; neurodevelopmental disorder epigenetic changes; histone lysine methylation; lysine methyltransferase; lysine demethylase; neurodevelopmental disorder

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Kim, J.-H.; Lee, J.H.; Lee, I.-S.; Lee, S.B.; Cho, K.S. Histone Lysine Methylation and Neurodevelopmental Disorders. Int. J. Mol. Sci. 2017, 18, 1404.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top